| A Clinical Study of BAT4406F Injection in Patients With Minimal Change Disease/Focal Segmental Glomerulosclerosis (NCT07499700) | Bio-Thera Solutions | 2025-10-26 |
| A Study Evaluating BAT3306 Compared With Keytruda® in NSCLC Cancer Participants (NCT07180862) | Bio-Thera Solutions | 2025-10-14 |
| A Clinical Study to Observe How Well That BAT8006 Works on Patients With Platinum Resistance Ovarian Cancer (NCT06545617) | Bio-Thera Solutions | 2025-01-31 |
| Efficacy Evaluation Study of BAT5906 and Lucentis® in Patients With Diabetic Macular Edema (NCT07515079) | Bio-Thera Solutions | 2024-10-09 |
| A Study to Evaluate PK, Efficacy, and Safety of BAT3306 Plus Chemo and Compare With Keytruda®(EU/US) in Participants With IV nqNSCLC (NCT06280196) | Bio-Thera Solutions | 2024-07-19 |
| A Multicenter Open Clinical Study of Safety, Tolerability, Pharmacokinetic Profile, and Initial Clinical Efficacy of BAT 8010 for Injection Combined With BAT 1006 in the Treatment of Locally Advanced or Metastatic Tumors (NCT06376136) | Bio-Thera Solutions | 2024-05-08 |
| A Clinical Study Evaluating the Safety, Tolerability, Pharmacokinetic Characteristics, and Preliminary Efficacy of the Combination of BAT8008 With BAT1308 in Patients With Advanced Solid Tumors (NCT06341114) | Bio-Thera Solutions | 2024-04-12 |
| BAT1308 in Combination With Platinum-containing Chemotherapy is Used for the First-line Treatment of Advanced or Recurrent dMMR Endometrial Cancer (NCT06321068) | Bio-Thera Solutions | 2024-04-09 |
| BAT1308 Combined with Platinum-Based Chemotherapy± Bevacizumab for PDL1-Positive (CPS ≥1) Cervical Cancer (NCT06123884) | Bio-Thera Solutions | 2023-12-13 |
| Evaluate the Safety, Tolerability of BAT6026 (NCT06094179) | Bio-Thera Solutions | 2023-11-09 |
| Compare the Pharmacokinetics and Safety of BAT3306 Injection Versus KEYTRUDA® Administered in Healthy Male Subjects (NCT06111196) | Bio-Thera Solutions | 2023-11-05 |
| A Randomized, Double-blind, Single-dose, Two-arm Parallel Study to Compare the Pharmacokinetics and Safety of BAT1806 Prefilled Subcutaneous Injection With RoActemra® in Healthy Chinese Male Subjects (NCT05968508) | Bio-Thera Solutions | 2023-08-29 |
| A Clinical Trial of BAT4406F Injection in Patients With Neuromyelitis Optica Spectrum Disorders (NCT06044350) | Bio-Thera Solutions | 2023-08-01 |
| A Comparative Pharmacokinetic Study to Evaluate Different Manufacturing Batches of BAT1706 Injection (NCT05865574) | Bio-Thera Solutions | 2023-06-01 |
| Clinical Study of Stage IV Psoriasis in Children With Geleli (NCT05803187) | Bio-Thera Solutions | 2023-04-05 |
| Assessment of Safety, Tolerability and Pharmacokinetics With BAT8010 for Injection in Advanced Malignant Solid Tumors Patients (NCT05848466) | Bio-Thera Solutions | 2023-02-10 |
| To Evaluate the Safety, Tolerance and Pharmacokinetics of BAT8007 for Injection in Patients With Advanced Solid Tumors (NCT05879627) | Bio-Thera Solutions | 2023-01-17 |
| Evaluate the Safety, Tolerability and Pharmacokinetic Characteristics of BAT8008 for Injection (NCT05620017) | Bio-Thera Solutions | 2022-11-30 |
| Assessment on Efficacy and Safety of BAT2306 and Cosentyx® in Plaque Psoriasis Patients (NCT05377944) | Bio-Thera Solutions | 2022-10-26 |
| Assess Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of BAT8009 (NCT05405621) | Bio-Thera Solutions | 2022-08-02 |
| A Study on Pharmacokinetics and Safety of BAT2506 Injection Versus Simponi® (NCT05332730) | Bio-Thera Solutions | 2022-08-01 |
| Efficacy Evaluation Study of BAT5906 and Lucentis® in Patients With Macular Degeneration (NCT05439629) | Bio-Thera Solutions | 2022-07-07 |
| Evaluate the Safety, Tolerability and Pharmacokinetic Characteristics of BAT8006 for Injection (NCT05378737) | Bio-Thera Solutions | 2022-07-06 |
| Evaluate the Pharmacokinetics of BAT2022 in Healthy Chinese Subjects (NCT05518695) | Bio-Thera Solutions | 2022-06-09 |
| Comparative Study to Evaluate the Pharmacokinetics of BAT2306 vs Cosentyx® in Healthy Subjects (NCT04711343) | Bio-Thera Solutions | 2022-06-08 |
| BAT7104 in Patients With Advanced Solid Tumours (NCT05200013) | Bio-Thera Solutions | 2022-04-29 |
| Assessment of Safety and Preliminary Efficacy With BAT6026 in Solid Tumour Patients (NCT05109650) | Bio-Thera Solutions | 2022-02-28 |
| Assessment of Safety and Preliminary Efficacy With BAT6021 in Solid Tumor Patients in China (NCT05120375) | Bio-Thera Solutions | 2022-02-17 |
| Evaluating the Safety, Tolerability, and Pharmacokinetics of BAT1006 (NCT05414136) | Bio-Thera Solutions | 2022-02-10 |
| BAT7104 Injection in Patients With Advanced Malignant Tumors. (NCT05767060) | Bio-Thera Solutions | 2022-01-20 |
| Assessment of Safety , Clinical Efficacy with QLETLI in Non-infectious Uveitis (UV) (NCT05180526) | Bio-Thera Solutions | 2021-12-27 |
| Assessment of Safety and Preliminary Efficacy With BAT6026 in Solid Tumor Patients in China (NCT05105971) | Bio-Thera Solutions | 2021-12-23 |
| Assessment of Safety and Preliminary Clinical Efficacy with BAT6005 in Advanced Malignant Solid Tumors (NCT05116709) | Bio-Thera Solutions | 2021-11-12 |
| Assessment of Safety and Preliminary Efficacy With BAT6021 in Solid Tumor Patients (NCT05073484) | Bio-Thera Solutions | 2021-10-29 |
| Assessment of Safety ,Tolerance and Pharmacokinetics Clinical Efficacy With BAT4706 in Advanced Solid Tumors (NCT05148325) | Bio-Thera Solutions | 2021-09-02 |
| Comparative Study of BAT2206 With Stelara® in Patients With Moderate to Severe Plaque Psoriasis (NCT04728360) | Bio-Thera Solutions | 2021-07-06 |
| Comparative Study of BAT2506 With Simponi® in Participants With Active Psoriatic Arthritis (NCT05046431) | Bio-Thera Solutions | 2021-05-06 |
| A Phase 1/2 Study to Assess Safety and Efficacy of BAT2020 in Hospitalized COVID-19 Patients (NCT04432766) | Bio-Thera Solutions | 2020-10-20 |
| Study of Two Multiple Intravitreal Doses of BAT5906 for Safety and Efficacy in Patients With Diabetic Macular Edema (NCT04772105) | Bio-Thera Solutions | 2020-10-16 |
| Assessment of Safety ,Tolerance and Pharmacokinetics Clinical Efficacy With BAT1308 in Advanced Solid Tumors (NCT05155722) | Bio-Thera Solutions | 2020-09-17 |
| A Phase I Clinical Trial of BAT4406F Injection in Patients With Neuromyelitis Optica Spectrum Disorders (NCT04146285) | Bio-Thera Solutions | 2020-09-01 |
| Clinical Study on the Efficacy and Safety of BAT5906 Injection (NCT05141994) | Bio-Thera Solutions | 2020-08-26 |
| Comparative Study to Evaluate the Pharmacokinetics of BAT2206 vs Stelara® in Healthy Subjects (NCT04371185) | Bio-Thera Solutions | 2020-08-08 |
| Comparative Study to Evaluate the Pharmacokinetics of BAT2506 vs Simponi® in Healthy Subjects (NCT04152759) | Bio-Thera Solutions | 2019-09-09 |
| Clinical Trial of BAT8003 (for Injection) for Patients With Advanced Epithelial Cancer (NCT03884517) | Bio-Thera Solutions | 2019-03-15 |
| Comparative Study of BAT1806 to RoActemra® in Rheumatoid Arthritis Patients With Inadequate Response to Methotrexate (NCT03830203) | Bio-Thera Solutions | 2018-12-19 |
| A Phase I Clinical Trial of BAT5906 Injection in Patients With Wet Age-related Macular Degeneration (NCT04151212) | Bio-Thera Solutions | 2018-10-30 |
| A Phase I Clinical Trial of BAT4306F on Safety, Tolerability and Pharmacokinetics for Patients (NCT04152148) | Bio-Thera Solutions | 2018-09-04 |
| The Efficacy and Safety of BAT8001 Injection for the Treatment of HER2-positive Advanced Breast Cancer (NCT04185649) | Bio-Thera Solutions | 2018-07-01 |
| Comparative Study to Evaluate the Pharmacokinetics of BAT1806 vs Actemra® in Healthy Subjects (NCT03606876) | Bio-Thera Solutions | 2018-06-13 |
| A Comparative Study of BAT1706 and EU Avastin® in Patients With Advanced Non Squamous Non Small Cell Lung Cancer (NCT03329911) | Bio-Thera Solutions | 2017-10-20 |